<DOC>
	<DOCNO>NCT02052336</DOCNO>
	<brief_summary>Primary Objective : To assess effect coadministration multiple dose CJ-12420 clarithromycin pharmacokinetics ( PK ) CJ-12420 clarithromycin . Secondary Objective ( ) : To assess safety coadministration multiple dose CJ-12420 clarithromycin healthy subject</brief_summary>
	<brief_title>Drug-Drug Interaction Study Between CJ-12420 Clarithromycin Healthy Male Subjects</brief_title>
	<detailed_description>An open-label , randomize , 6-sequence , 3-period , 3-treatment crossover design</detailed_description>
	<mesh_term>Clarithromycin</mesh_term>
	<criteria>Healthy male volunteer age 19 45 year old Body mass index ( BMI ) range 19 28 kg/m2 Understand requirement study voluntarily consent paticipate study History clinically significant medical history disease ( hepatic , kidney , gastrointestinal , respiratory , musculoskeletal , endocrine , neuropsychiatric , haematooncologic , urinary tract , cardiac arrhythmia cardiovascular system ) judge investigator . Clinically significant abnormal laboratory result within least 28 day prior first day drug administration . AST ALT &gt; 1.25 time upper limit value Total bilirubin &gt; 1.5 time upper limit value estimate GFR : less 80 mL/min Clinically significant abnormal ECG result within least 28 day prior first day drug administration PR ≥ 210 msec QRS ≥ 120 msec QT ≥ 500 msec QTcF ≥ 500 msec Clinically significant hypersensitivity reaction investigational drug drug history drug abuse `` positive '' result drug screen test . Take medicine prescription medicine herbal medicine , overthecounter drug , vitamin supplement Person intake history food drug affect drug absorption , drug distribution , drug metabolism , drug excretion bowel activity Volunteer history donation whole blood donation , apheresis , transfusion Volunteer heavy drinker ( 30g/day ) , smoker ( 10 cigarettes/day ) , heavy caffeine consumer ( 400mg/day )</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Drug-Drug interaction</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>